## Abstract Persistent B19 parvovirus infection has been recognized in immunocompromised patients, often occurring with a low‐titer viremia. In this study, nested polymerase chain reaction (PCR) for the detection of B19 parvovirus DNA was carried out on the sera of 49 human immunodeficiency virus (
Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine
✍ Scribed by Jeffrey A. Connell; John V. Parry; Philip P. Mortimer; Julian Duncan
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 573 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Epidemiological evidence and laboratory studies indicate that human immunodeficiency virus type 1 (HIV 1) is rarely, if ever, transmitted in saliva or urine. In that both specimens are easy to collect, each may be a useful alternative to serum specimens for anti‐HIV screening. A rapid, simple, and robust IgG‐capture enzyme‐linked immunsorbent assay (GACELISA) suitable for the detection of anti‐HIV 1 and 2 in saliva and urine was developed. Following optimisation of the assay, 177 salivary and 568 urine specimens collected from individuals of known serostatus were investigated. The assay was 100% sensitive on 50 salivary (median OD/CO = 8.9) and 126 urinary (median OD/CO = 8.6) specimens collected from anti‐HIV‐positive patients. The specificity was 100% on 127 salivary specimens (median OD/CO = 0.37) and 422 urinary specimens (median OD/CO = 0.39) collected from anti‐HIV‐negative individuals. These findings demonstrate that GACELISA HIV 1 + 2 tests on saliva or on urine are an accurate alternative to a conventional anti‐HIV test of blood. This assay is satisfactory for surveillance purposes and, with appropriate precautions, could be used clinically.
📜 SIMILAR VOLUMES
## Abstract The possible transmission routes of hepatitis C virus (HCV) in patients without overt parenteral exposure (sporadic or community acquired form) were examined. Saliva and urine specimens obtained from type C hepatitis patients, whose sera were positive for the HCV genome, were examined b
Since the characterization of the genome of the hepatitis E virus (HEV) in 1990, a large genetic diversity has been described. A single real-time reverse transcription (RT)-PCR assay with TaqMan technology has been validated which uses only one set of primers and probe within the ORF2 HEV region (nt